{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:43:49Z","timestamp":1793036629265,"version":"4.5.0"},"reference-count":161,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Atrial fibrillation (AF) and diabetes mellitus frequently coexist and together define a high-risk cardiometabolic phenotype. Diabetes is associated with an increased incidence of AF, although this relationship is strongly influenced by obesity, hypertension, chronic kidney disease (CKD), heart failure (HF), sleep-disordered breathing, and broader metabolic risk clustering. Once AF develops, diabetes is associated with greater thromboembolic and HF risk, impaired quality of life, cognitive vulnerability, and excess mortality. These adverse outcomes may be partly explained by a multidimensional atrial substrate, described here within the conceptual framework of diabetic atrial cardiomyopathy, in which hyperglycaemia, insulin resistance, glycaemic variability, oxidative stress, inflammation, autonomic dysfunction, microvascular disease, lipotoxicity, and epicardial adipose tissue dysfunction may contribute to atrial fibrosis, electrical heterogeneity, impaired calcium handling, mitochondrial injury, and mechanical dysfunction. Collectively, these abnormalities may facilitate AF initiation, persistence, progression, and recurrence after rhythm-control interventions. Management should therefore extend beyond rhythm control and anticoagulation alone. In individuals at increased risk of AF, priorities include cardiometabolic optimization, treatment of obesity, hypertension, CKD, HF, and sleep apnoea, lifestyle intervention, and selective rhythm surveillance. In subclinical AF, decisions regarding anticoagulation should account for AF burden, thromboembolic and bleeding risk, renal function, frailty, and patient preference. In established AF, stroke prevention, symptom-directed rate or rhythm control, cardiometabolic therapy, and longitudinal reassessment remain central. This narrative review integrates the epidemiology, mechanisms, and management of AF in diabetes across the continuum from AF risk to subclinical and clinical disease.<\/jats:p>","DOI":"10.3390\/jcm15135024","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:20Z","timestamp":1782722720000},"page":"5024","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Atrial Fibrillation in Diabetes: Epidemiology, Mechanisms and Integrated Management"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-5713","authenticated-orcid":false,"given":"Paschalis","family":"Karakasis","sequence":"first","affiliation":[{"name":"Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9260-6306","authenticated-orcid":false,"given":"Panagiotis","family":"Theofilis","sequence":"additional","affiliation":[{"name":"First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6739-1024","authenticated-orcid":false,"given":"Konstantinos","family":"Grigoriou","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Athens, 75 Mikras Asias Avenue, 11527 Goudi, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5768-9125","authenticated-orcid":false,"given":"Panagiotis","family":"Iliakis","sequence":"additional","affiliation":[{"name":"First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Department of Medicine, Division of Cardiology, Angiology and Internal Emergency Medicine, Ruhr University Bochum, Knappschaft Kliniken University Hospital Bochum, 44892 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-4942","authenticated-orcid":false,"given":"Panayotis K.","family":"Vlachakis","sequence":"additional","affiliation":[{"name":"First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0995-7015","authenticated-orcid":false,"given":"Nikolaos","family":"Ktenopoulos","sequence":"additional","affiliation":[{"name":"First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-7952","authenticated-orcid":false,"given":"Anastasios","family":"Apostolos","sequence":"additional","affiliation":[{"name":"First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Department of Cardiology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, Harefield Hospital, London UB9 6JH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Chatzichidiroglou","sequence":"additional","affiliation":[{"name":"Department of Midwifery, International Hellenic University, 57001 Thessaloniki, Greece"},{"name":"Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences Aristotle, University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-1352","authenticated-orcid":false,"given":"Theocharis","family":"Koufakis","sequence":"additional","affiliation":[{"name":"Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences Aristotle, University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-5581","authenticated-orcid":false,"given":"Antonios P.","family":"Antoniadis","sequence":"additional","affiliation":[{"name":"Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-684X","authenticated-orcid":false,"given":"Dimitrios","family":"Patoulias","sequence":"additional","affiliation":[{"name":"Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences Aristotle, University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7158-4950","authenticated-orcid":false,"given":"Nikolaos","family":"Fragakis","sequence":"additional","affiliation":[{"name":"Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week","volume":"74","author":"Wang","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"euaf027","DOI":"10.1093\/europace\/euaf027","article-title":"Global, Regional, and National Burden of Atrial Fibrillation and Atrial Flutter from 1990 to 2021: Sex Differences and Global Burden Projections to 2046\u2014A Systematic Analysis of the Global Burden of Disease Study 2021","volume":"27","author":"Tan","year":"2025","journal-title":"Europace"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"euae195","DOI":"10.1093\/europace\/euae195","article-title":"Global Burden of Atrial Fibrillation\/Atrial Flutter and Its Attributable Risk Factors from 1990 to 2021","volume":"26","author":"Cheng","year":"2024","journal-title":"Europace"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th Edition of the IDF Diabetes Atlas: Global, Regional, and National Diabetes Prevalence Estimates for 2024 and Projections for 2050","volume":"14","author":"Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/ejhf.3347","article-title":"Diabetic Myocardial Disorder. A Clinical Consensus Statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases","volume":"26","author":"Paulus","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lorenzo-Almor\u00f3s, A., Casado Cerrada, J., \u00c1lvarez-Sala Walther, L.-A., M\u00e9ndez Bail\u00f3n, M., and Lorenzo Gonz\u00e1lez, \u00d3. (2023). Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?. J. Clin. Med., 12.","DOI":"10.3390\/jcm12082868"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"euae204","DOI":"10.1093\/europace\/euae204","article-title":"Atrial Cardiomyopathy Revisited-Evolution of a Concept: A Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Hear","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Karakasis, P., Theofilis, P., Vlachakis, P.K., Ktenopoulos, N., Patoulias, D., Antoniadis, A.P., and Fragakis, N. (2025). Atrial Cardiomyopathy in Atrial Fibrillation: Mechanistic Pathways and Emerging Treatment Concepts. J. Clin. Med., 14.","DOI":"10.3390\/jcm14093250"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"euaf038","DOI":"10.1093\/europace\/euaf038","article-title":"Left Atrial Intramyocardial Fat at Pulmonary Vein Reconnection Sites during Atrial Fibrillation Redo Ablation","volume":"27","author":"Landra","year":"2025","journal-title":"Europace"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"156463","DOI":"10.1016\/j.metabol.2025.156463","article-title":"Effect of GLP-1 Receptor Agonists and Co-Agonists on Atrial Fibrillation Risk in Overweight or Obesity: Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"175","author":"Karakasis","year":"2026","journal-title":"Metabolism"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4070\/kcj.2023.0234","article-title":"Lower Atrial Fibrillation Risk with Sodium-Glucose Cotransporter 2 Inhibitors Than with Dipeptidyl Peptidase-4 Inhibitors in Individuals with Type 2 Diabetes: A Nationwide Cohort Study","volume":"54","author":"Kim","year":"2024","journal-title":"Korean Circ. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108579","DOI":"10.1016\/j.jdiacomp.2023.108579","article-title":"Risk of Atrial Fibrillation in Individuals with Dysglycemia and Diabetes","volume":"37","author":"Kriegbaum","year":"2023","journal-title":"J. Diabetes Complicat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/joim.13688","article-title":"Diabetes, Prediabetes, and Atrial Fibrillation\u2014A Population-Based Cohort Study Based on National and Regional Registers","volume":"294","author":"Johansson","year":"2023","journal-title":"J. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/heartjnl-2011-300503","article-title":"Type 2 Diabetes, Glucose Homeostasis and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study","volume":"98","author":"Huxley","year":"2012","journal-title":"Heart"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12933-021-01422-3","article-title":"Impaired Fasting Glucose: A Risk Factor for Atrial Fibrillation and Heart Failure","volume":"20","author":"Lind","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","article-title":"Prediabetes and Risk of Mortality, Diabetes-Related Complications and Comorbidities: Umbrella Review of Meta-Analyses of Prospective Studies","volume":"65","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100693","DOI":"10.1016\/j.lanepe.2023.100693","article-title":"Sex-Specific Risks for Cardiovascular Disease across the Glycaemic Spectrum: A Population-Based Cohort Study Using the UK Biobank","volume":"32","author":"Rentsch","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart Disease and Stroke Statistics: A Report of US and Global Data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"110875","DOI":"10.1016\/j.diabres.2023.110875","article-title":"Trends and Burden of Diabetes in Patients with Atrial Fibrillation during 2007\u20132018: A Finnish Nationwide Cohort Study","volume":"203","author":"Teppo","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/heartjnl-2019-315397","article-title":"Epidemiology of Atrial Fibrillation in Northeast China: A Cross-Sectional Study, 2017\u20132019","volume":"106","author":"Xing","year":"2020","journal-title":"Heart"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00592-022-01864-5","article-title":"Shared Exposure Liability of Type 2 Diabetes and Other Chronic Conditions in the UK Biobank","volume":"59","author":"He","year":"2022","journal-title":"Acta Diabetol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S2213-8587(17)30262-0","article-title":"Risk of Atrial Fibrillation in People with Type 1 Diabetes Compared with Matched Controls from the General Population: A Prospective Case-Control Study","volume":"5","author":"Dahlqvist","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"110629","DOI":"10.1016\/j.diabres.2023.110629","article-title":"Association of Type 1 Diabetes Mellitus and Risk of Atrial Fibrillation: Systematic Review and Meta-Analysis","volume":"199","author":"Guo","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-019-0953-7","article-title":"Risk of Early Mortality and Cardiovascular Disease in Type 1 Diabetes: A Comparison with Type 2 Diabetes, a Nationwide Study","volume":"18","author":"Lee","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jacc.2015.10.080","article-title":"Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study","volume":"67","author":"Ashburner","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/eurjpc\/zwac093","article-title":"Prognostic Impact of Type 1 and Type 2 Diabetes Mellitus in Atrial Fibrillation and the Effect of Severe Hypoglycaemia: A Nationwide Cohort Study","volume":"29","author":"Karayiannides","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12933-021-01216-7","article-title":"Sex, Age, Type of Diabetes and Incidence of Atrial Fibrillation in Patients with Diabetes Mellitus: A Nationwide Analysis","volume":"20","author":"Bisson","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.2337\/dc23-0931","article-title":"Association Between Atrial Fibrillation and Diabetes-Related Complications: A Nationwide Cohort Study","volume":"46","author":"Kwon","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12933-021-01232-7","article-title":"Prognostic Significance of Diabetes Mellitus in Patients with Atrial Fibrillation","volume":"20","author":"Papazoglou","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.23736\/S2724-5683.22.05891-4","article-title":"The Connubium among Diabetes, Chronic Kidney Disease and Atrial Fibrillation","volume":"70","author":"Magnocavallo","year":"2022","journal-title":"Minerva Cardiol. Angiol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Bucci, T., Nabrdalik, K., Shantsila, A., Romiti, G.F., Teo, W.-S., Park, H.-W., Shimizu, W., Tse, H.-F., Proietti, M., and Chao, T.-F. (2024). Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry. J. Clin. Med., 13.","DOI":"10.3390\/jcm13051274"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Karakasis, P., Theofilis, P., Vlachakis, P.K., Apostolos, A., Ktenopoulos, N., Grigoriou, K., Patoulias, D., Antoniadis, A.P., and Fragakis, N. (2025). Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment. Life, 15.","DOI":"10.3390\/life15111675"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jacc.2017.07.755","article-title":"Care Patterns and Outcomes in Atrial Fibrillation Patients with and Without Diabetes: ORBIT-AF Registry","volume":"70","author":"Shrader","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e021800","DOI":"10.1161\/JAHA.121.021800","article-title":"Association of Diabetes with Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights from the Swiss-AF Study","volume":"10","author":"Bano","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12933-021-01318-2","article-title":"Relationship between Diabetes Mellitus and Atrial Fibrillation Prevalence in the Polish Population: A Report from the Non-Invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) Prospective Cross-Sectional Observational Study","volume":"20","author":"Gumprecht","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"17252","DOI":"10.1038\/s41598-023-43939-5","article-title":"Impact of Diabetes Mellitus Severity, Treatment Regimen and Glycaemic Control on Atrial Fibrillation Prevalence in the Polish Population Aged \u226565","volume":"13","author":"Gumprecht","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.2337\/dc22-0717","article-title":"Associations of New-Onset Atrial Fibrillation with Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients with Type 2 Diabetes","volume":"45","author":"Geng","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1111\/dom.15714","article-title":"Association between New-Onset Atrial Fibrillation and Dementia among Individuals with Type 2 Diabetes","volume":"26","author":"Zhou","year":"2024","journal-title":"Diabetes. Obes. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Militaru, M., Lighezan, D.F., Tudoran, C., and Militaru, A.G. (2024). Connections between Cognitive Impairment and Atrial Fibrillation in Patients with Diabetes Mellitus Type 2. Biomedicines, 12.","DOI":"10.3390\/biomedicines12030672"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.amjcard.2014.07.045","article-title":"Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)","volume":"114","author":"Fatemi","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1540-8167.2007.01037.x","article-title":"AGEs-RAGE System Mediates Atrial Structural Remodeling in the Diabetic Rat","volume":"19","author":"Kato","year":"2008","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-Associated Cardiac Fibrosis: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","article-title":"Cardiac Oxidative Stress in Diabetes: Mechanisms and Therapeutic Potential","volume":"172","author":"Faria","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jacc.2009.07.031","article-title":"Substrate-Specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human Heart","volume":"54","author":"Anderson","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacbts.2023.01.005","article-title":"Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice","volume":"8","author":"Bohne","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.hrthm.2024.02.036","article-title":"Calpain Inhibition Protects against Atrial Fibrillation by Mitigating Diabetes-Associated Atrial Fibrosis and Calcium Handling Dysfunction in Type 2 Diabetes Mice","volume":"21","author":"Wang","year":"2024","journal-title":"Heart Rhythm"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e171102","DOI":"10.1172\/jci.insight.171102","article-title":"Macrophage IL-1\u03b2 Mediates Atrial Fibrillation Risk in Diabetic Mice","volume":"9","author":"Zhou","year":"2024","journal-title":"JCI Insight"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e141213","DOI":"10.1172\/jci.insight.141213","article-title":"Atrial AMP-Activated Protein Kinase Is Critical for Prevention of Dysregulation of Electrical Excitability and Atrial Fibrillation","volume":"7","author":"Su","year":"2022","journal-title":"JCI Insight"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e008296","DOI":"10.1161\/CIRCEP.120.008296","article-title":"Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation","volume":"13","author":"McCauley","year":"2020","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"105268","DOI":"10.1016\/j.ebiom.2024.105268","article-title":"NR4A3 Prevents Diabetes Induced Atrial Cardiomyopathy by Maintaining Mitochondrial Energy Metabolism and Reducing Oxidative Stress","volume":"106","author":"Peng","year":"2024","journal-title":"EBioMedicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jjcc.2015.06.003","article-title":"Assessment of Atrial Electromechanical Delay and P-Wave Dispersion in Patients with Type 2 Diabetes Mellitus","volume":"67","author":"Demir","year":"2016","journal-title":"J. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10840-012-9722-1","article-title":"Atrial Conduction Time and Atrial Mechanical Function in Patients with Impaired Fasting Glucose","volume":"35","author":"Ayhan","year":"2012","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5603\/CJ.2013.0010","article-title":"Impaired Atrial Electromechanical Function and Atrial Fibrillation Promotion in Alloxan-Induced Diabetic Rabbits","volume":"20","author":"Fu","year":"2013","journal-title":"Cardiol. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"H86","DOI":"10.1152\/ajpheart.00010.2012","article-title":"Conduction and Refractory Disorders in the Diabetic Atrium","volume":"303","author":"Watanabe","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1074\/jbc.M114.607952","article-title":"Down-Regulation of the Small Conductance Calcium-Activated Potassium Channels in Diabetic Mouse Atria","volume":"290","author":"Yi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1074\/jbc.RA118.003837","article-title":"F-Box Protein-32 down-Regulates Small-Conductance Calcium-Activated Potassium Channel 2 in Diabetic Mouse Atria","volume":"294","author":"Ling","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"172444","DOI":"10.1016\/j.ejphar.2019.172444","article-title":"Increase of Late Sodium Current Contributes to Enhanced Susceptibility to Atrial Fibrillation in Diabetic Mice","volume":"857","author":"Jin","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1073\/pnas.1914853117","article-title":"Loss of Insulin Signaling May Contribute to Atrial Fibrillation and Atrial Electrical Remodeling in Type 1 Diabetes","volume":"117","author":"Polina","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e95747","DOI":"10.1172\/JCI95747","article-title":"Oxidized CaMKII and O-GlcNAcylation Cause Increased Atrial Fibrillation in Diabetic Mice by Distinct Mechanisms","volume":"131","author":"Mesubi","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.hrthm.2020.08.019","article-title":"Electrical and Structural Remodeling Contribute to Atrial Fibrillation in Type 2 Diabetic Db\/Db Mice","volume":"18","author":"Bohne","year":"2021","journal-title":"Heart Rhythm"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrendo.2012.21","article-title":"Cardiovascular Autonomic Neuropathies as Complications of Diabetes Mellitus","volume":"8","author":"Kuehl","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Benichou, T., Pereira, B., Mermillod, M., Tauveron, I., Pfabigan, D., Maqdasy, S., and Dutheil, F. (2018). Heart Rate Variability in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195166"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdiacomp.2014.09.002","article-title":"Autonomic Dysfunction Is Associated with Brief Episodes of Atrial Fibrillation in Type 2 Diabetes","volume":"29","author":"Rizzo","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The Clinical Profile and Pathophysiology of Atrial Fibrillation: Relationships among Clinical Features, Epidemiology, and Mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1536\/ihj.50.627","article-title":"Influences of Autonomic Nervous System on Atrial Arrhythmogenic Substrates and the Incidence of Atrial Fibrillation in Diabetic Heart","volume":"50","author":"Otake","year":"2009","journal-title":"Int. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yjmcc.2015.02.024","article-title":"Altered Parasympathetic Nervous System Regulation of the Sinoatrial Node in Akita Diabetic Mice","volume":"82","author":"Krishnaswamy","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e008919","DOI":"10.1161\/JAHA.118.008919","article-title":"Pulmonary Vein Ganglia Are Remodeled in the Diabetic Heart","volume":"7","author":"Bassil","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12933-024-02185-3","article-title":"Prevalence and Prognostic Significance of Cardiac Autonomic Neuropathy in Community-Based People with Type 2 Diabetes: The Fremantle Diabetes Study Phase II","volume":"23","author":"Davis","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of Oxidative Stress by Acute Glucose Fluctuations Compared with Sustained Chronic Hyperglycemia in Patients with Type 2 Diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/cvr\/cvu176","article-title":"Glucose Fluctuations Increase the Incidence of Atrial Fibrillation in Diabetic Rats","volume":"104","author":"Saito","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_73","first-page":"410","article-title":"Impact of Long-Term Glycemic Variability on Development of Atrial Fibrillation in Type 2 Diabetic Patients","volume":"18","author":"Gu","year":"2017","journal-title":"Anatol. J. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jdiacomp.2017.09.009","article-title":"Severe Hypoglycemia Is a Risk Factor for Atrial Fibrillation in Type 2 Diabetes Mellitus: Nationwide Population-Based Cohort Study","volume":"32","author":"Ko","year":"2018","journal-title":"J. Diabetes Complicat."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-021-01341-3","article-title":"Higher Long-Term Visit-to-Visit Glycemic Variability Predicts New-Onset Atrial Fibrillation in Patients with Diabetes Mellitus","volume":"20","author":"Hsu","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/dom.14615","article-title":"Glycaemic Variability in Patients with Type 2 Diabetes Mellitus Treated with Dulaglutide, with and without Concomitant Insulin: Post Hoc Analyses of Randomized Clinical Trials","volume":"24","author":"Romera","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Ma, M., Zhi, H., Yang, S., Yu, E.Y.-W., and Wang, L. (2022). Body Mass Index and the Risk of Atrial Fibrillation: A Mendelian Randomization Study. Nutrients, 14.","DOI":"10.3390\/nu14091878"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12933-023-01777-9","article-title":"U-Shaped Association between the Triglyceride-Glucose Index and Atrial Fibrillation Incidence in a General Population without Known Cardiovascular Disease","volume":"22","author":"Liu","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/cvr\/cvv208","article-title":"Human Epicardial Adipose Tissue Has a Specific Transcriptomic Signature Depending on Its Anatomical Peri-Atrial, Peri-Ventricular, or Peri-Coronary Location","volume":"108","author":"Gaborit","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","article-title":"Human Epicardial Adipose Tissue Induces Fibrosis of the Atrial Myocardium through the Secretion of Adipo-Fibrokines","volume":"36","author":"Venteclef","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1161\/CIRCULATIONAHA.120.052009","article-title":"Extracellular Vesicles from Epicardial Fat Facilitate Atrial Fibrillation","volume":"143","author":"Ram","year":"2021","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.hroo.2023.10.007","article-title":"MicroRNAs in Extracellular Vesicles Released from Epicardial Adipose Tissue Promote Arrhythmogenic Conduction Slowing","volume":"4","author":"Ernault","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.hrthm.2012.03.024","article-title":"Determinants of Atrial Fibrillation in an Animal Model of Obesity and Acute Obstructive Sleep Apnea","volume":"9","author":"Iwasaki","year":"2012","journal-title":"Heart Rhythm"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/cvr\/cvab024","article-title":"NLRP3 Inflammasome Is a Key Driver of Obesity-Induced Atrial Arrhythmias","volume":"117","author":"Scott","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_85","first-page":"1962","article-title":"Gut Microbiota Dysbiosis Induced by a High-Fat Diet Increases Susceptibility to Atrial Fibrillation","volume":"38","author":"Kong","year":"2022","journal-title":"Can. J. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2395565","DOI":"10.1080\/21623945.2024.2395565","article-title":"The Change of Epicardial Adipose Tissue Characteristics and Vulnerability for Atrial Fibrillation upon Drastic Weight Loss","volume":"13","author":"Meulendijks","year":"2024","journal-title":"Adipocyte"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1253\/circj.CJ-15-0138","article-title":"Role of Inflammation in Atrial Fibrillation Pathophysiology and Management","volume":"79","author":"Harada","year":"2015","journal-title":"Circ. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","article-title":"Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study","volume":"116","author":"McGavock","year":"2007","journal-title":"Circulation"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI16751","article-title":"Lipoprotein Lipase (LpL) on the Surface of Cardiomyocytes Increases Lipid Uptake and Produces a Cardiomyopathy","volume":"111","author":"Yagyu","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.CIR.100.22.2248","article-title":"Arrhythmias and Conduction Defects as Presenting Symptoms of Fatty Acid Oxidation Disorders in Children","volume":"100","author":"Bonnet","year":"1999","journal-title":"Circulation"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00395-015-0497-2","article-title":"Arrhythmia Causes Lipid Accumulation and Reduced Glucose Uptake","volume":"110","author":"Lenski","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Fu, Y., Jiang, T., Liu, B., Sun, H., Zhang, Y., Fan, B., Li, X., Qin, X., and Zheng, Q. (2021). Enhancing Fatty Acids Oxidation via L-Carnitine Attenuates Obesity-Related Atrial Fibrillation and Structural Remodeling by Activating AMPK Signaling and Alleviating Cardiac Lipotoxicity. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.771940"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.amjmed.2022.04.012","article-title":"Burden of Microvascular Disease and Risk of Atrial Fibrillation in Adults with Type 2 Diabetes","volume":"135","author":"Kaze","year":"2022","journal-title":"Am. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2337\/dc19-2116","article-title":"Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients with Type 2 Diabetes: Findings from a Population-Based Cohort Study","volume":"43","author":"Adderley","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"111978","DOI":"10.1016\/j.diabres.2024.111978","article-title":"Relationship between Glycemic Variability and the Incidence of Postoperative Atrial Fibrillation Following Cardiac Surgery: A Retrospective Study from MIMIC-IV Database","volume":"219","author":"Zhou","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2026). 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. Diabetes Care, 49, S124\u2013S149.","DOI":"10.2337\/dc26-S006"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2026). 7. Diabetes Technology: Standards of Care in Diabetes-2026. Diabetes Care, 49, S150\u2013S165.","DOI":"10.2337\/dc26-S007"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12933-014-0169-9","article-title":"Effect of Empagliflozin Monotherapy on Postprandial Glucose and 24-Hour Glucose Variability in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled, 4-Week Study","volume":"14","author":"Nishimura","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12933-024-02545-z","article-title":"ANXA1-FPR2 Axis Mitigates the Susceptibility to Atrial Fibrillation in Obesity via Rescuing AMPK Activity in Response to Lipid Overload","volume":"23","author":"Liu","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00125-015-3666-9","article-title":"Risk Factors for Atrial Fibrillation in Type 2 Diabetes: Report from the Swedish National Diabetes Register (NDR)","volume":"58","author":"Zethelius","year":"2015","journal-title":"Diabetologia"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Saleeb-Mousa, J., Nathanael, D., Coney, A.M., Kalla, M., Brain, K.L., and Holmes, A.P. (2023). Mechanisms of Atrial Fibrillation in Obstructive Sleep Apnoea. Cells, 12.","DOI":"10.3390\/cells12121661"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"108170","DOI":"10.1016\/j.maturitas.2024.108170","article-title":"Obstructive Sleep Apnea Syndrome (OSAS) in Women: A Forgotten Cardiovascular Risk Factor","volume":"193","author":"Moscucci","year":"2025","journal-title":"Maturitas"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2017.05.008","article-title":"Women with Atrial Fibrillation and Type 2 Diabetes Have a Higher Incidence of Hospitalization and Undergo Ablation or Pacemaker Implantation Less Frequently than Men","volume":"42","author":"Villalba","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1038\/s41598-021-84307-5","article-title":"Lifestyle Is Associated with Atrial Fibrillation Development in Patients with Type 2 Diabetes Mellitus","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12933-024-02194-2","article-title":"Effect of Physical Activity on Incident Atrial Fibrillation in Individuals with Varying Duration of Diabetes: A Nationwide Population Study","volume":"23","author":"Choi","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12933-020-01105-5","article-title":"SGLT2 Inhibitors and Atrial Fibrillation in Type 2 Diabetes: A Systematic Review with Meta-Analysis of 16 Randomized Controlled Trials","volume":"19","author":"Li","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12933-020-01162-w","article-title":"The Risk of New-Onset Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus Treated with Sodium Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors","volume":"19","author":"Ling","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2022.07.015","article-title":"Screening for Atrial Fibrillation in the Elderly: A Network Meta-Analysis of Randomized Trials","volume":"105","author":"Elbadawi","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/eurheartj\/ehac547","article-title":"Cost-Effectiveness of Population Screening for Atrial Fibrillation: The STROKESTOP Study","volume":"44","author":"Lyth","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"euaf145","DOI":"10.1093\/europace\/euaf145","article-title":"Timing of Stroke Risk Reassessment in Atrial Fibrillation Patients with a CHA2DS2-VA Score of 0 or 1: The Norwegian AFNOR Study","volume":"27","author":"Anjum","year":"2025","journal-title":"Europace"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2013.02.091","article-title":"Brief Episodes of Silent Atrial Fibrillation Predict Clinical Vascular Brain Disease in Type 2 Diabetic Patients","volume":"62","author":"Marfella","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"107711","DOI":"10.1016\/j.jdiacomp.2020.107711","article-title":"Silent Atrial Fibrillation Detected by Home-Monitoring: Cardiovascular Disease and Stroke Prevention in Patients with Diabetes","volume":"34","author":"Tingsgaard","year":"2020","journal-title":"J. Diabetes Complicat."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacep.2017.06.020","article-title":"Detection of Subclinical Atrial Fibrillation in High-Risk Patients Using an Insertable Cardiac Monitor","volume":"3","author":"Philippsen","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Nteli, M., Nteli, D., Moysidis, D.V., Foka, A., Zymaris, P., Grantza, T., Kazarli, O., Vagianos, A., Papazoglou, A.S., and Kartas, A. (2024). Prognostic Impact of Body Mass Index in Atrial Fibrillation. J. Clin. Med., 13.","DOI":"10.3390\/jcm13113294"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of Device-Detected Subclinical Atrial Fibrillation and Occurrence of Stroke in ASSERT","volume":"38","author":"Healey","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The Relationship between Daily Atrial Tachyarrhythmia Burden from Implantable Device Diagnostics and Stroke Risk: The TRENDS Study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-Detected Atrial Fibrillation and Risk for Stroke: An Analysis of >10,000 Patients from the SOS AF Project (Stroke PreventiOn Strategies Based on Atrial Fibrillation Information from Implanted Devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical Atrial Fibrillation and the Risk of Stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/j.jacc.2019.09.050","article-title":"Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders","volume":"74","author":"Diederichsen","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/eurheartj\/ehae790","article-title":"Artificial Intelligence-Derived Electrocardiographic Aging and Risk of Atrial Fibrillation: A Multi-National Study","volume":"46","author":"Cho","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(19)31721-0","article-title":"An Artificial Intelligence-Enabled ECG Algorithm for the Identification of Patients with Atrial Fibrillation during Sinus Rhythm: A Retrospective Analysis of Outcome Prediction","volume":"394","author":"Attia","year":"2019","journal-title":"Lancet"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/eurheartj\/ehaf073","article-title":"Near-Term Prediction of Sustained Ventricular Arrhythmias Applying Artificial Intelligence to Single-Lead Ambulatory Electrocardiogram","volume":"46","author":"Fiorina","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Karakasis, P., Theofilis, P., Sagris, M., Pamporis, K., Stachteas, P., Sidiropoulos, G., Vlachakis, P.K., Patoulias, D., Antoniadis, A.P., and Fragakis, N. (2025). Artificial Intelligence in Atrial Fibrillation: From Early Detection to Precision Therapy. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082627"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/ehjcvp\/pvx037","article-title":"Management and Prognosis of Atrial Fibrillation in Diabetic Patients: An EORP-AF General Pilot Registry Report","volume":"4","author":"Fumagalli","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: The ARREST-AF Cohort Study","volume":"64","author":"Pathak","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_130","first-page":"1929","article-title":"PREVEntion and RegReSsive Effect of Weight-Loss and Risk Factor Modification on Atrial Fibrillation: The REVERSE-AF Study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"EP Eur."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Sclafani, M., Spartera, M., Esmati, Y., Baynham-Williams, O., Khan, I., Brigoli, M., Krasopoulos, C., Ormerod, J., Tang, P.-T., and Rider, O. (2026). Weight Loss in Older Patients With Persistent Atrial Fibrillation: The LOSE-AF Randomized Clinical Trial. JAMA, e265787.","DOI":"10.1001\/jama.2026.5787"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"euae054","DOI":"10.1093\/europace\/euae054","article-title":"Association between Sodium-Glucose Cotransporter-2 Inhibitors and Arrhythmic Outcomes in Patients with Diabetes and Pre-Existing Atrial Fibrillation","volume":"26","author":"Fichadiya","year":"2024","journal-title":"Europace"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ejhf.1663","article-title":"Efficacy of Empagliflozin on Heart Failure and Renal Outcomes in Patients with Atrial Fibrillation: Data from the EMPA-REG OUTCOME Trial","volume":"22","author":"Slawik","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jacep.2022.08.004","article-title":"Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Catheter Ablation for Atrial Fibrillation","volume":"8","author":"Kishima","year":"2022","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"132359","DOI":"10.1016\/j.ijcard.2024.132359","article-title":"Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation: A Systemic Review and Meta-Analysis","volume":"413","author":"Zhang","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/jce.14954","article-title":"Effect of Metformin on Outcomes of Catheter Ablation for Atrial Fibrillation","volume":"32","author":"Deshmukh","year":"2021","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Zhang, X., Korantzopoulos, P., Letsas, K.P., Tse, G., Gong, M., Meng, L., Li, G., and Liu, T. (2017). Thiazolidinedione Use and Atrial Fibrillation in Diabetic Patients: A Meta-Analysis. BMC Cardiovasc. Disord., 17.","DOI":"10.1186\/s12872-017-0531-4"},{"key":"ref_138","first-page":"387","article-title":"PPAR\u03b3 Agonist Use and Recurrence of Atrial Fibrillation after Successful Electrical Cardioversion","volume":"58","author":"Gu","year":"2017","journal-title":"Hell. J. Cardiol."},{"key":"ref_139","unstructured":"Shubietah, A., Elgendy, M.S., Awashra, A., Murad, M.R., Alqudah, M., Gowaily, I., Mohamed, A.A., Emara, A., Olumuyide, E., and Elbataa, A. Effect of GLP-1 Receptor Agonists on Post-Ablation Atrial Fibrillation Recurrence: A Meta-Analysis. Pacing Clin. Electrophysiol., Epub ahead of printing."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"102742","DOI":"10.1016\/j.cpcardiol.2024.102742","article-title":"Effects of Mineralocorticoid Receptor Antagonists on New-Onset or Recurrent Atrial Fibrillation: A Bayesian and Frequentist Network Meta-Analysis of Randomized Trials","volume":"49","author":"Karakasis","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_141","unstructured":"Goldberger, J.J., Mitrani, R.D., Fishman, J., Zaatari, G., Lowery, M., Baez-Garcia, C., Aguilar, V., Blandon, C., Hurwitz, B.E., and Velasquez, A.H. The Liraglutide Effects in Atrial Fibrillation (LEAF) Study. JACC Clin. Electrophysiol., in press."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/eurjpc\/zwae249","article-title":"The Association of Haemoglobin A1c Variability with Adverse Outcomes in Patients with Atrial Fibrillation Prescribed Anticoagulants","volume":"31","author":"Huang","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Acanfora, D., Ciccone, M.M., Carlomagno, V., Scicchitano, P., Acanfora, C., Bortone, A.S., Uguccioni, M., and Casucci, G. (2021). A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132924"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Russo, V., Attena, E., Rago, A., Melillo, E., Di Micco, P., Papa, A.A., Napolitano, G., D\u2019Onofrio, A., Golino, P., and Nigro, G. (2020). Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061621"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e2876","DOI":"10.1002\/dmrr.2876","article-title":"Safety and Efficacy of Nonvitamin K Antagonist Oral Anticoagulants versus Warfarin in Diabetic Patients with Atrial Fibrillation: A Study-Level Meta-Analysis of Phase III Randomized Trials","volume":"33","author":"Patti","year":"2017","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.amjcard.2016.11.023","article-title":"Comparison of the Incidence of Major Bleeding with Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients with Versus Without Diabetes Mellitus","volume":"119","author":"Peacock","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.amjcard.2023.06.054","article-title":"Percutaneous Left Atrial Appendage Closure Among Patients with Diabetes (Insights from a National Database)","volume":"202","author":"Hamed","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcin.2022.02.009","article-title":"Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients with Atrial Fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5936180","DOI":"10.1155\/2018\/5936180","article-title":"Risk Factors for Failure of Direct Current Cardioversion in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation","volume":"2018","author":"Soran","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1213\/01.ane.0000229709.29185.88","article-title":"Diabetes Mellitus Reduces the Antiarrhythmic Effect of Ion Channel Blockers","volume":"103","author":"Ito","year":"2006","journal-title":"Anesth. Analg."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1540-8167.2008.01275.x","article-title":"Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation versus Antiarrhythmic Drug Therapy","volume":"20","author":"Forleo","year":"2009","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10840-006-9049-x","article-title":"Safety and Efficacy of Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus\u2014Single Center Experience","volume":"17","author":"Tang","year":"2006","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/clc.23667","article-title":"Atrial Fibrillation Catheter Ablation Complications in Obese and Diabetic Patients: Insights from the US Nationwide Inpatient Sample 2005\u20132013","volume":"44","author":"Elshazly","year":"2021","journal-title":"Clin. Cardiol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Guckel, D., Isgandarova, K., Bergau, L., Piran, M., El Hamriti, M., Imnadze, G., Braun, M., Khalaph, M., Fink, T., and Sciacca, V. (2021). The Effect of Diabetes Mellitus on the Recurrence of Atrial Fibrillation after Ablation. J. Clin. Med., 10.","DOI":"10.3390\/jcm10214863"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"euae104","DOI":"10.1093\/europace\/euae104","article-title":"Comprehensive Atrial Fibrillation Burden and Symptom Reduction Post-Ablation: Insights from DECAAF II","volume":"26","author":"Noujaim","year":"2024","journal-title":"Europace"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.120.051558","article-title":"Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results from the CABANA Trial","volume":"143","author":"Russo","year":"2021","journal-title":"Circulation"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Karakasis, P., Vlachakis, P.K., Theofilis, P., Ktenopoulos, N., Patoulias, D., Fyntanidou, B., Antoniadis, A.P., and Fragakis, N. (2025). Atrial Cardiomyopathy in Atrial Fibrillation: A Multimodal Diagnostic Framework. Diagnostics, 15.","DOI":"10.3390\/diagnostics15101207"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Stachteas, P., Bantidos, M.G., Papoutsidakis, N., Nasoufidou, A., Karakasis, P., Sidiropoulos, G., Kofos, C., Patoulias, D., Ediaroglou, V., and Stavropoulos, G. (2025). Monitoring Atrial Fibrillation Using Wearable Digital Technologies: The Emerging Role of Smartwatches. J. Clin. Med., 15.","DOI":"10.3390\/jcm15010014"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Proietti, R., Rivera-Caravaca, J.M., L\u00f3pez-G\u00e1lvez, R., Harrison, S.L., Mar\u00edn, F., Underhill, P., Shantsila, E., McDowell, G., Vinciguerra, M., and Davies, R. (2023). Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12082814"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Parsi, S., Sonavane, K., Ravi, U., Shirsat, P.D., Chamarthi, V.S., Gabr, M., Ponnam, H.C., Surani, S., Bansal, V., and Kashyap, R. (2025). Effects of Sodium Glucose Co-Transporter 2 Inhibitors on Atrial Fibrillation Recurrences After Catheter Ablation in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14228001"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/5024\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:48:03Z","timestamp":1783532883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/5024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":161,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15135024"],"URL":"https:\/\/doi.org\/10.3390\/jcm15135024","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]}}}